Best Warren Buffett Stocks To Own Right Now

Facebook COO Sheryl Sandberg plans to donate all of her shares in SurveyMonkey to charity when it goes public.

The “Lean In” author owns 9.9% of the company. She joined the startup’s board after her late-husband Dave Goldberg died suddenly while on vacation in Mexico in 2015. Goldberg was the CEO.

SurveyMonkey revealed the planned donation in its IPO filing on Wednesday.

“Ms. Sandberg plans to donate all shares beneficially owned by her (or the proceeds from the sale thereof) to the Sheryl Sandberg and Dave Goldberg Family Foundation as part of fulfilling their philanthropic commitment to the Giving Pledge,” the filing said.

The Giving Pledge is an initiative created Warren Buffett and Bill and Melinda Gates to encourage the wealthy to donate some of their money to charitable causes.

Sandberg’s foundation supports her causes Lean In and Option B. The former creates programs that “advance opportunities for all women” and the latter supports people deal with grief after a loss, according to the website.

Best Warren Buffett Stocks To Own Right Now: Littelfuse Inc.(LFUS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Littelfuse (NASDAQ:LFUS) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a report issued on Thursday.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Littelfuse (LFUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Timothy Green]

    Circuit-protection product manufacturer Littelfuse (NASDAQ:LFUS) reported its second-quarter results before the market opened on Aug. 1. Revenue soared thanks to the acquisition of IXYS and double-digit organic growth, while adjusted earnings grew at a slower rate. The company provided guidance calling for strong growth in the third quarter, despite the impact from tariffs.

  • [By Ethan Ryder]

    Littelfuse, Inc. (NASDAQ:LFUS) SVP Matthew Cole sold 150 shares of the business’s stock in a transaction dated Wednesday, August 8th. The shares were sold at an average price of $227.26, for a total transaction of $34,089.00. Following the transaction, the senior vice president now directly owns 4,163 shares of the company’s stock, valued at $946,083.38. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

  • [By Stephan Byrd]

    KAMES CAPITAL plc lessened its holdings in Littelfuse, Inc. (NASDAQ:LFUS) by 0.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 315,223 shares of the technology company’s stock after selling 2,678 shares during the period. Littelfuse comprises approximately 1.5% of KAMES CAPITAL plc’s portfolio, making the stock its 27th biggest position. KAMES CAPITAL plc owned about 1.26% of Littelfuse worth $62,373,000 at the end of the most recent quarter.

Best Warren Buffett Stocks To Own Right Now: UniSource Energy Corporation(UNS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Uni Select (TSE:UNS) had its price target lifted by investment analysts at Macquarie from C$24.00 to C$25.00 in a report released on Wednesday. Macquarie’s price objective suggests a potential upside of 18.32% from the stock’s current price.

  • [By Max Byerly]

    Uni Select (TSE:UNS)‘s stock had its “hold” rating restated by equities research analysts at TD Securities in a report issued on Friday. They currently have a C$24.00 price objective on the stock. TD Securities’ price target points to a potential upside of 8.21% from the stock’s current price.

Best Warren Buffett Stocks To Own Right Now: Qualys, Inc.(QLYS)

Advisors’ Opinion:

  • [By Max Byerly]

    Asset Management One Co. Ltd. grew its stake in shares of Qualys Inc (NASDAQ:QLYS) by 32.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,110 shares of the software maker’s stock after purchasing an additional 1,980 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Qualys were worth $590,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Qualys (QLYS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Qualys Inc (NASDAQ:QLYS)’s share price reached a new 52-week high and low on Monday . The stock traded as low as $86.00 and last traded at $85.60, with a volume of 20160 shares changing hands. The stock had previously closed at $83.55.

  • [By ]

    Qualys (QLYS) : “I think this is a good company, but everything is coming down, so let’s wait to buy some more.”

    HEICO (HEI) : “We’re not buying anything at a 52-week high — but on a pullback, you bet.”

  • [By Shane Hupp]

    TRADEMARK VIOLATION WARNING: “Stock Traders Buy Large Volume of Qualys Call Options (QLYS)” was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at www.tickerreport.com/banking-finance/4147960/stock-traders-buy-large-volume-of-qualys-call-options-qlys.html.

Best Warren Buffett Stocks To Own Right Now: Safe Bulkers Inc(SB)

Advisors’ Opinion:

  • [By Rich Smith]

    Ocean-going bulk shipper Safe Bulkers (NYSE:SB) reported its fiscal Q1 2018 earnings results on Tuesday — an “earnings beat” that nudged the company’s shares up 2%. But it took until Thursday for the real good news to arrive. Today, all of the sudden, the stock jumped out of its berth and closed 12.2% higher.

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    SpartanNash Company (NASDAQ: SPTN) is projected to post quarterly earnings at $0.53 per share on revenue of $2.38 billion.
    HP Inc. (NYSE: HPQ) is expected to post quarterly earnings at $0.48 per share on revenue of $13.57 billion.
    salesforce.com, inc. (NYSE: CRM) is projected to post quarterly earnings at $0.47 per share on revenue of $2.94 billion.
    HEICO Corporation (NYSE: HEI) is estimated to post quarterly earnings at $0.53 per share on revenue of $424.96 million.
    Safe Bulkers, Inc. (NYSE: SB) is expected to post quarterly earnings at $0.02 per share on revenue of $41.10 million

  • [By Shane Hupp]

    These are some of the media stories that may have effected Accern Sentiment’s scoring:

    Get Safe Bulkers alerts:

    Safe Bulkers, Inc. Agrees with Cosco Shipping Heavy Industry Co. Ltd. to Install Alfa Laval PureSOx Scrubbers (finance.yahoo.com) Analysts Anticipate Safe Bulkers, Inc. (SB) to Post $0.06 EPS (americanbankingnews.com) Safe Bulkers Inc.: Safe Bulkers, Inc. Announces Election of Class I Directors at 2018 Annual Meeting of Stockholders (twst.com) Critical Analysis: Dorian LPG (LPG) & Safe Bulkers (SB) (americanbankingnews.com)

    A number of analysts have recently weighed in on SB shares. TheStreet cut Safe Bulkers from a “c-” rating to a “d+” rating in a research report on Thursday. Maxim Group reiterated a “buy” rating and set a $6.00 price target on shares of Safe Bulkers in a research report on Monday, July 23rd. Zacks Investment Research cut Safe Bulkers from a “buy” rating to a “hold” rating in a research report on Tuesday, June 12th. ValuEngine upgraded Safe Bulkers from a “sell” rating to a “hold” rating in a research report on Friday, June 1st. Finally, Seaport Global Securities upgraded Safe Bulkers from a “neutral” rating to a “buy” rating and increased their price target for the stock from $3.50 to $5.00 in a research report on Tuesday, July 31st. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $3.79.

Best Warren Buffett Stocks To Own Right Now: XO Group, Inc.(XOXO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    SinglePoint, Inc. Common Stock (NYSE: XOXO) and XO Group, Inc. Common Stock (NYSE:XOXO) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, valuation, dividends, profitability, analyst recommendations and institutional ownership.

  • [By Dan Caplinger]

    Tuesday was a mixed day on Wall Street, with tech stocks picking up modest amounts of ground even as broader market measures declined. Investors had a number of events to focus on, including harsh words from President Trump on the trade front and the beginning of a two-day meeting of the Federal Reserve’s monetary policy committee to discuss a potential interest rate hike. Even with popular indexes generally staying close to where they began the session, a few stocks posted big gains. Square (NYSE:SQ), XO Group (NYSE:XOXO), and The Trade Desk (NASDAQ:TTD) were among the best performers on the day. Here’s why they did so well.

  • [By Max Byerly]

    SinglePoint, Inc. Common Stock (NYSE: XOXO) and XO Group, Inc. Common Stock (NYSE:XOXO) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, risk, profitability and earnings.

  • [By Logan Wallace]

    SinglePoint (NYSE: XOXO) and XO Group (NYSE:XOXO) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations.

  • [By Max Byerly]

    ValuEngine upgraded shares of XO Group (NYSE:XOXO) from a buy rating to a strong-buy rating in a research report sent to investors on Wednesday morning.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on XO Group, Inc. Common Stock (XOXO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *